NFC for Pharmaceutical Anti-Counterfeiting and Drug Traceability: Securing the Global Medicine Supply Chain

Counterfeit medicines pose a $200B+ global threat, endangering patient safety and brand integrity. This article explores how NFC technology — via tamper-evident tags, encrypted authentication, and cold-chain monitoring — delivers end-to-end traceability for pharmaceuticals, supporting EU FMD, US DSCSA, and WHO compliance while empowering patients and healthcare providers with instant verification.

By |2026-05-07T09:58:00+08:00May 9th, 2026|Digital_Product_Passport, Smart_management|
Go to Top